OTIC Insider Trading Activity and SEC Form 4 Filings
OTIC insider trading summary
No open-market insider purchases or sales of Otonomy, Inc. (OTIC) have been reported on SEC Form 4 in the past 12 months.
Latest OTIC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 28, 2022 | Vickie L Capps | Director | Sell | $4K (42,242 @ $0.10) |
| Mar 28, 2022 | David Allen Weber | President & CEO | Sell | $27K (11,243 @ $2.41) |
| Mar 28, 2022 | Paul E Cayer | Ch. Financial & Business Offcr | Sell | $14K (5,624 @ $2.41) |
| Mar 28, 2022 | Robert Michael Savel II | Chief Technical Officer | Sell | $8K (3,325 @ $2.41) |
| Mar 28, 2022 | Alan Charles Foster | Chief Scientific Officer | Sell | $6K (2,559 @ $2.41) |
| Mar 25, 2022 | Paul E Cayer | Ch. Financial & Business Offcr | Sell | $10K (4,015 @ $2.39) |
| Mar 25, 2022 | Alan Charles Foster | Chief Scientific Officer | Sell | $4K (1,827 @ $2.39) |
| Mar 25, 2022 | Robert Michael Savel II | Chief Technical Officer | Sell | $6K (2,374 @ $2.39) |
| Mar 25, 2022 | David Allen Weber | President & CEO | Sell | $19K (8,026 @ $2.39) |
| Mar 3, 2021 | Jay Lichter | Director | Sell | $307K (113,935 @ $2.70) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.